Table 2B Mipsagargin dose levels evaluated
Dose escalation (n=28) | |
|---|---|
Mipsagargin dose (mg m −2) (days 1, 2 and 3) | Number of patients |
1.2 | 3 |
2.5 | 3 |
5 | 3 |
10 | 3 |
20 | 3 |
40 | 4 |
66.8 | 6 |
88 | 3 |
Dose expansion (n=16) | |
Mipsagargin dose (mg m −2) (day 1/day 2/day 3) | Number of patients |
40/66.8/66.8 | 16 |
